DREAMM12

A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function

Arms / Cohorts

Experimental Arm:Patients with Normal / Mild Impaired Renal Function

Accepting patients

Experimental Arm:Patients with Severe Renal Impairment

Accepting patients

Experimental Arm:Patients with End Stage Renal Disease, Not on Dialysis

Accepting patients

Experimental Arm:Patients with End Stage Renal Disease, On Dialysis

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.